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Abstract
Background: The E2F family of transcription factors is required for the activation or repression
of differentially expressed gene programs during the cell cycle in normal and abnormal
development of tissues. We previously determined that members of the retinoblastoma protein
family that interacts with the E2F family are differentially expressed and localized in almost all the
different cell types and tissues of the testis and in response to known endocrine disruptors. In this
study, the cell-specific and stage-specific expression of members of the E2F proteins has been
elucidated.
Methods: We used immunohistochemical (IHC) analysis of tissue sections and Western blot
analysis of proteins, from whole testis and microdissected stages of seminiferous tubules to study
the differential expression of the E2F proteins.
Results: For most of the five E2F family members studied, the localizations appear conserved in
the two most commonly studied rodent models, mice and rats, with some notable differences.
Comparisons between wild type and E2F-1 knockout mice revealed that the level of E2F-1 protein
is stage-specific and most abundant in leptotene to early pachytene spermatocytes of stages IX to
XI of mouse while strong staining of E2F-1 in some cells close to the basal lamina of rat tubules
suggest that it may also be expressed in undifferentiated spermatogonia. The age-dependent
development of a Sertoli-cell-only phenotype in seminiferous tubules of E2F-1 knockout males
corroborates this, and indicates that E2F-1 is required for spermatogonial stem cell renewal.
Interestingly, E2F-3 appears in both terminally differentiated Sertoli cells, as well as spermatogonial
cells in the differentiative pathway, while the remaining member of the activating E2Fs, E2F-2 is
most concentrated in spermatocytes of mid to late prophase of meiosis. Comparisons between
wildtype and E2F-4 knockout mice demonstrated that the level of E2F-4 protein displays a distinct
profile of stage-specificity compared to E2F-1, which is probably related to its prevalence and role
in Sertoli cells. IHC of rat testis indicates that localization of E2F-5 is distinct from that of E2F-4
and overlaps those of E2F-1 and E2F-2.
Conclusion: The E2F-1 represents the subfamily of transcription factors required during stages of
DNA replication and gene expression for development of germ cells and the E2F-4 represents the
subfamily of transcription factors that help maintain gene expression for a terminally differentiated
state within the testis.
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Background
The testis provides an exceptional system for studying fate
determination, differentiation, and death (apoptosis),
interposed on mitosis and meiosis, and all these inter-
twined processes occurring in a single population of cells.
The stages or fixed groups of cells undergoing different
phases of spermatogenesis develop as a wave along the
seminiferous tubule, continuously cycling over time.
Spermatogonial stem cells are supposedly "awakened"
from a quiescent state by signals such as glial cell line-
derived neurotrophic factor (GDNF), and subsequent
path selection maybe determined by the ratio of follicle
stimulating hormone (FSH) to GDNF favoring differenti-
ation over renewal, respectively [Fig. 1, adapted from [1]].
Subsequently, and concurrent with proliferation of type A
spermatogonia committed to differentiation, stem cell
Stage-specificity of spermatogonial renewal, proliferation, differentiation, and its regulation, as reviewed by Dirk G. de Rooij [1] Figure 1
Stage-specificity of spermatogonial renewal, proliferation, differentiation, and its regulation, as reviewed by Dirk G. de Rooij 
[1]. Abbreviations: As = spermatogonial stem cell, Apr = paired spermatogonia, Aal-n = aligned spermatogonia of n number of 
cells, An = differentiated type A spermatogonia entering synchronised division number n, In = intermediate type spermatogonia, 
B = B-type spermatogonia which undergo final mitotic division before replication and division for Meiosis I, GDNF/Ret are the 
ligand/receptor tyrosine kinase complex for glial cell-line derived neurotrophic factor (GDNF) signaling, GFRα1 is the glycosyl-
phosphatidylinositol (GPI)-achored coreceptor for GDNF/Ret, SCF/c-kit are the ligand/receptor complex for stem cell factor 
(SCF) signaling, Dazl is the deleted in azoospermia-like gene, and Bax and Bcl-XL are pro-apoptopic and anti-apoptopic Bcl-2 
protein family members respectively.
stages VII-VIII
Adapted from de Rooij, D.G.
(2001). Reproduction
121, 347-354. © Society for
Reproduction and Fertility.
Reproduced by permission.Reproductive Biology and Endocrinology 2006, 4:63 http://www.rbej.com/content/4/1/63
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factor (SCF) and retinoic acid are critical for survival and
differentiation. Mitotic division and orientation away
from the basement membrane, i.e. asymmetric mitosis, is
also suggested to influence commitment to differentiation
inasmuch as at least one daughter of an asymmetric
mitotic division would be shifted away from the stem cell
niche and towards the lower concentration of a gradient
of signals, e.g. desert hedgehog, that repress differentia-
tion [2]. Finally, in adult males, wherein the number of
terminally differentiated Sertoli cells capable of support-
ing spermatogenesis has been established, normal sperm
production, estimated at 1000/second in human [3],
depends on the tight regulation of active proliferation, dif-
ferentiation, and death [4].
The retinoblastoma protein (pRb) and related proteins
p107 and p130 are key mediators of cell cycle arrest, dif-
ferentiation, proliferation, senescence, and apoptosis, in
response to a wide variety of signals. They fulfill their cen-
tral role by interacting with a multitude of other proteins.
The retinoblastoma protein is thought to interact with
over 110 different partners [5], including transcription
factors, to regulate the expression of genes affecting a cell's
state of quiescence or differentiation, cycles of replication
and division in active proliferation, or death. Most nota-
ble amongst pRb partners are the members of the E2F
family of transcription factors. Different pRbs have prefer-
ential binding partners of the E2F family, and the expres-
sion of both partners is dependent on the stage of the cell
cycle [6]. The pRbs are themselves tightly regulated by
posttranslational modifications, especially phosphoryla-
tion at specific threonines and serines, catalyzed by cyclin
dependant kinases (CDKs), which are regulated by cyc-
lins. The levels of G1 cyclin D can be increased transcrip-
tionally, translationally, or postranslationally by kinase-
driven signal transduction pathways, which are activated
upstream by signals that a cell receives, often referred to as
the "context" of a cell. FSH and SCF are two of the key sig-
nals known to affect the differentiation of young (type A)
spermatogonia, and both are known to affect an increase
in cyclin D levels [7,8]. Since pRb is the principal substrate
for cyclin D regulated CDKs 4 and 6, which initiate phos-
phorylation of pRb and its release of E2Fs 1–4, it is
expected that the dynamic control of gene expression pro-
grams of spermatogenesis dependent on FSH and SCF be
driven through interactions between the pRb and E2F
families.
Our previous study of the retinoblastoma family of pro-
teins (henceforth abbreviated pRbs) revealed differential
expression and localization in the testis, indicating spe-
cialized roles for these cell cycle regulators and their part-
ners in the development and maintenance of testis in rats
[9,10]. Interestingly, the stage-specific expression pattern
of pRb in Sertoli cells (highest at stages VII-VIII) disap-
pears during days 2–20 after ethylene-dimethane sul-
fonate (EDS) treatment when testosterone levels are
undetectable, suggesting that pRb levels can be affected by
androgens. The level and phosphorylation status of p130
correlated with Leydig cell apoptosis: during the first days
after EDS treatment, when massive Leydig cell apoptosis
occurs, the level of p130 decreased and it became hypo-
phosphorylated. Knockout mice have been invaluable to
studies directed at determining the true biological roles of
the pRbs, but reports of testis phenotypes have been con-
spicuously lacking. In contrast, knockout of E2F-1 pro-
duced testicular atrophy [11] with a Sertoli-cell-only
(empty tubules) phenotype, and the addition of a
hemizygous E2F-3 knockout to a full knockout of E2F-1
accelerates the development of testicular atrophy [12],
even though knockout of E2F-3 alone exerts no effect on
testis. This exacerbated phenotype in the compound or
double knockout (DKO) suggested overlap in the biolog-
ical roles of E2F-1 and E2F-3 in the testis. A knockout of
an atypical member of the family, E2F-6, also generated a
testis phenotype, manifesting Leydig cell hyperplasia and
incomplete filling of epididymal ducts [13]. Knockout of
E2F-4 causes infertility in both sexes, though the gonads
appeared histologically normal [14,15]. These knockouts
expressing testis phenotypes and the knockout of E2F-5
[16] and E2F-2 [17], which generated hydrocephaly and
autoimmune phenotypes, respectively, underscore the
critical role of E2Fs in regulating gene expression pro-
grams necessary for normal tissue differentiation and org-
anogenesis. The study described herein was initiated in
order to determine how the retinoblastoma and E2F fam-
ilies might interact to control the maintenance of testicu-
lar tissue organization, and the entry of undifferentiated
quiescent spermatogonial cells into the mitotic prolifera-
tion leading to meiosis and differentiation into spermato-
zoa. The cell- and stage-specific localization of E2Fs in the
testis from the study herein, compared to our previously
developed map of the pRbs in testis [9,10], correlates with
traditional paradigms of partnerships between different
family members and their roles in regulating the expres-
sion of programs of genes required for active proliferation
versus differentiation. However, some of our results may
also suggest a more independent role for certain members
or unexpected partnerships between these two protein
families.
Materials and methods
The E2F-1 -/- mice [18], B6;129S4-E2f1tm1Meg/J, and
control mice (B6129SF2/J) were purchased from the Jack-
son Laboratory. Patrick Humbert generously provided the
E2F-4 -/- mice [14] and E2F-5/mice [16]. FVB/N mice were
obtained from breeding stocks of the Transgenic Core
Facility and Sprague-Dawley rats were obtained from
breeding stocks of the Central Animal Laboratory of the
University of Turku. All procedures performed on animalsReproductive Biology and Endocrinology 2006, 4:63 http://www.rbej.com/content/4/1/63
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were in strict accordance with the European Convention
for the Protection of Vertebrate Animals used for Experi-
mental and other Scientific Purposes (ETS No.123),
Appendix A: Guidelines for accommodation and care of
animals, and the European Union Directive 86/609/ETY
on the protection of animals used for experimental and
other scientific purposes.
For the immunohistochemical analysis of E2Fs, sections
of paraformaldehyde-fixed and paraffin-embedded
(FFPE) testis were deparaffinized and rehydrated as
described elsewhere [19]. For antigen retrieval, slides were
incubated in 10 mM citrate buffer pH 6.0 heated to boil-
ing in a microwave oven, for ten minutes [20,21]. Staining
with primary monoclonal antibodies, counterstaining
with horseradish peroxidase (HRP)-conjugated anti-
mouse IgG secondary antibody, and the staining with per-
oxidase substrate were performed using the PowerVision+
and Homomouse IHC kits and protocols from Immuno-
Vision Technologies, Co. The primary antibodies used for
immunohistochemistry were mouse monoclonal anti-
bodies (MAbs) of the same immunoglobulin isotype and
light chain against E2F-1, E2F-2 and E2F-4, and a syn-
thetic hapten which is normally not present animals (neg-
ative control) purchased from Lab Vision Corporation, a
mouse monoclonal antibody against E2F-3 from Upstate,
a mouse monoclonal antibody against E2F-5 from Santa
Cruz Biotechnology, Inc., rabbit polyclonal antibodies
against p107, SMADs (small mothers against decapenta-
plegic) 1/2/3, SMAD 4 and androgen receptor (positive
control) from Santa Cruz Biotechnology, Inc., and a rab-
bit polyclonal antibody against a synthetic hapten which
is normally not present in animals (negative control)
from Lab Vision Corporation. Staining with negative con-
trol antibodies was always performed with at least the
same dilution as the least dilute test antibody. Immuno-
histochemistry results were collated from repeated analy-
ses of sections of testis from at least three individuals of
each species, rat and mouse testes sections stained at the
same time, and sections of testes from at least three pairs
of littermates or age-matched (8 weeks or older) individ-
uals of wild type and knockout mice from each line
stained at the same time. The primary antibodies used for
Western blot analyses were MAbs against E2F-1 and E2F-
4 from Lab Vision Corporation, a MAb against E2F-4 pro-
vided by Jacqueline Lees, and a MAb against glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) from HyTest
Ltd. The HRP-conjugated secondary antibodies used in
Western blot analysis were purchased from Amersham
Biosciences.
Segments containing defined stages of mouse seminifer-
ous tubule were microdissected from the testis of adult
animals, on a transilluminating stereomicroscope [22]
and flash-frozen in liquid nitrogen. Total proteins were
extracted by homogenizing frozen tubules directly into an
extraction buffer (Cell Cycle Methods booklet 4, Bio-
source International) containing a cocktail of protease
inhibitors (complete Mini, from Roche Diagnostics
GmbH) and activated orthovanadate (protocol from
Upstate), briefly vortexing to facilitate thawing, and pas-
saging 6–8 times through a 25G 5/8" needle using a 1 ml
syringe. The resulting extracts were incubated at room
temperature for 15 min, before centrifugation at 16 000 g
for 4°C. Then the extracts were kept on ice if the concen-
trations of protein were to be determined right away or
flash-freeze in liquid nitrogen before storing at -80°C. The
concentrations of protein in different extracts were quan-
titated by bicinchoninic acid (BCA) assay from Pierce.
One hundred micrograms samples of the protein extracts
were resolved through sodium dodecyl sulfate polyacryla-
mide gel electrophoresis (SDS-PAGE), with a 4% acryla-
mide stacking gel and 8% acrylamide resolving gel.
Western transfer to a polyvinylidene fluoride (PVDF)
membrane was performed as described elsewhere [23],
except that ethanol was used in place of methanol in the
transfer buffer. After immunostaining with primary and
secondary antibodies, bands were detected on blots by
treatment for enhanced chemiluminescent (ECL) detec-
tion with the enhanced ECL plus kit (Amersham-Bio-
sciences) and exposure on Fuji Rx 100 X-ray film. The level
of GAPDH protein, i.e. stained band intensity, was used as
a control on immunostained Western blots, for quantita-
tion of total proteins by BCA assay, and for loading and
transfer of total proteins in SDS-PAGE and electrophoretic
transfer.
The developed films were scanned on a UMAX Astra
2000U and densitometric analysis of specific bands was
performed with the Image J (1.37u) software by Wayne
Rasband, the National Institutes of Health, USA. Data
from at least three independent experiments were proc-
essed for statistical analysis of variance (ANOVA) for
repeated measures by the WINKS 4.80a software from
TexaSoft, USA. Using the Newman-Keuls multiple com-
parisons test, the means of relative levels of E2F for differ-
ent pooled stage(s) were not considered significantly
different at the 0.05 significance level, while differences
between the means were judged as significant at a p <
0.025, and plots of the means reflect these groupings.
Results
Localizations of E2F-1, E2F-2 and E2F-3
Staining for E2F-1 appears to be somewhat different for
rat compared to mouse testis (Fig. 3), the IHCs have in
common the staining of nuclei of spermatocytes from lep-
totene to early pachytene, most evident in stages XI to XI.
The specificity of staining by the anti-E2F-1 MAb on
wildtype mouse sections was established by simultane-
ously staining these sections alongside sections from anReproductive Biology and Endocrinology 2006, 4:63 http://www.rbej.com/content/4/1/63
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E2F-1 -/- (knockout) (Fig. 3), wherein hardly any staining
is visible above that obtained for the negative control
MAb (Fig. 2). Staining of rat sections with anti-E2F-1 also
reveals some type A3 spermatogonia in stages XIII, as well
as type A and intermediate type spermatogonia in stages II
to V, and IX (Fig. 3, and Fig. 11). These observations from
immunohistochemistry for E2F-1 are in concordance with
the results from Western blot analyses that displayed a
most distinct increase in the level of a 56 kDa protein cor-
responding to E2F-1, which was absent from separated
sample of E2F-1 knockout testis (data not shown),
between stages VIII and IX of mouse (Fig. 16). E2F-2 is
localized most abundantly in the nuclei of pachytene and
diplotene spermatocytes of stages VII-XIII, but also lighter
staining of secondary spematocytes at stage XIV of rat is
apparent (Fig. 4 and Fig. 12). E2F-3 is most strongly
stained in the nuclei of type A, intermediate and type B
spermatogonia of stages II to V of rat, with lighter staining
in Sertoli cells of other stages (Fig. 5, and Fig. 13). The
antibody against E2F-3 stained Sertoli cells in mouse testis
sections more strongly than on rat testis sections.
Differential compartmentalization of E2F-4 and E2F-5
The antibody against E2F-4 stained the nuclei of the
somatic cells (Leydig, Sertoli and peritubular myoid cells)
of the testis most strongly, and especially so the Leydig
cells. However, parallel staining of testis sections from
E2F-4 knockout mice demonstrated that only staining of
Sertoli cells was absent (data not shown). The staining of
Sertoli cells appears darker in stages IV to VI than in other
stages (Fig. 6, and Fig. 14). The antibody used to detect
E2F-5 in the rat testis, where it most intensely stained
nuclei of type B spermatogonia, preleptotene and pach-
ytene spermatocytes in stages from IV to VIII (Fig. 7, and
Fig. 15) did not stain sections of wild type and E2F-5
knockout mouse testis specifically under any of the condi-
tions tested, in parallel experiments. At higher magnifica-
tion, staining of rat testis sections with anti-E2F-5 appears
to display a perinuclear or diffuse cytoplasmic staining in
zygotene spermatocytes of stage XIII to late pachytene of
stage VII. Staining for p107 appears most prevalent in dif-
ferentiating spermatogonia, and lesser in early spermato-
cytes in meiosis (Fig. 8), while stainings for SMADs 1/2/3
(R-SMADs) and SMAD 4 (N-SMAD) revealed strongest
localization of these in spermatogonia and spermatocytes
up to the pachytene stage, but not beyond (Figures 9 and
10).
Western blot analyses demonstrated a 65 kDa protein cor-
responding to E2F-4 (Paul Danielen, MIT, personal com-
munication) present in samples extracted from wild type
(E2F-4 +/+) and heterozygous (E2F-4 +/-) mouse testis,
but absent in protein samples from testis of E2F-4 knock-
out siblings, separated in parallel. The level of the E2F-4
band increased between stages VI and VII, and then pla-
teaued over remaining stages of the seminiferous epithe-
lium (Fig. 17). It was not possible to detect specifically
E2F-5 protein in wild type compared to E2F-5 knockout
mouse testis. Nevertheless, Western blot analyses of pro-
tein extracts from ten pooled stages of microdissected rat
Immunohistochemical staining of sections from testis of mouse and rat with antibody against synthetic negative control peptide Figure 2
Immunohistochemical staining of sections from testis of mouse and rat with antibody against synthetic negative control peptide.
Mouse RatReproductive Biology and Endocrinology 2006, 4:63 http://www.rbej.com/content/4/1/63
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Immunohistochemical staining of sections from testis of mouse, E2F-1 knockout mouse, and rat with antibody against E2F-1 Figure 3
Immunohistochemical staining of sections from testis of mouse, E2F-1 knockout mouse, and rat with antibody against E2F-1. 
Labels are: for germline type A spermatogonia (A), intermediate (I) and B-type (B) spermatogonia, preleptotene (Pl), pach-
ythene (P), zygotene (Z), and diplotene (D)spermatocytes, spermatids (s), and for somatic Sertoli cell (S), Leydig cell (L), and 
peritubular myoid cell (M); stages indicated by Roman numerals I-XIV for rat and I-XII for mouse.
Rat
E2F-1 knockout mouse
Mouse MouseReproductive Biology and Endocrinology 2006, 4:63 http://www.rbej.com/content/4/1/63
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Immunohistochemical staining of sections from testis of mouse and rat with antibody against E2F-2 Figure 4
Immunohistochemical staining of sections from testis of mouse and rat with antibody against E2F-2. Labels are: for germline 
type A spermatogonia (A), intermediate (I) and B-type (B) spermatogonia, preleptotene (Pl), pachythene (P), zygotene (Z), and 
diplotene (D)spermatocytes, spermatids (s), and for somatic Sertoli cell (S), Leydig cell (L), and peritubular myoid cell (M); 
stages indicated by Roman numerals I-XIV for rat and I-XII for mouse.
VII
P
Pl
Z
D
XIII
XI
P
XIII
Rat
MouseReproductive Biology and Endocrinology 2006, 4:63 http://www.rbej.com/content/4/1/63
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Immunohistochemical staining of sections from testis of mouse and rat with antibody against E2F-3 Figure 5
Immunohistochemical staining of sections from testis of mouse and rat with antibody against E2F-3. Labels are: for germline 
type A spermatogonia (A), intermediate (I) and B-type (B) spermatogonia, preleptotene (Pl), pachythene (P), zygotene (Z), and 
diplotene (D)spermatocytes, spermatids (s), and for somatic Sertoli cell (S), Leydig cell (L), and peritubular myoid cell (M); 
stages indicated by Roman numerals I-XIV for rat and I-XII for mouse.
Mouse
RatReproductive Biology and Endocrinology 2006, 4:63 http://www.rbej.com/content/4/1/63
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Immunohistochemical staining of sections from testis of mouse and rat with antibody against E2F-4 Figure 6
Immunohistochemical staining of sections from testis of mouse and rat with antibody against E2F-4. Labels are: for germline 
type A spermatogonia (A), intermediate (I) and B-type (B) spermatogonia, preleptotene (Pl), pachythene (P), zygotene (Z), and 
diplotene (D)spermatocytes, spermatids (s), and for somatic Sertoli cell (S), Leydig cell (L), and peritubular myoid cell (M); 
stages indicated by Roman numerals I-XIV for rat and I-XII for mouse.
Mouse
RatReproductive Biology and Endocrinology 2006, 4:63 http://www.rbej.com/content/4/1/63
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testis stained with antibody for detescting E2F-5 detected
a protein about 65 kDa band that peaked between stages
II-III and IV-V just before the stageVI transition of the sem-
iniferous epithelium (data not shown). Preliminary RT-
PCR results (not shown) for E2F-5 demonstrate its tran-
script level is constant throughout the cycle of the seminif-
erous epithelium.
Discussion
E2F-1
The detection of E2F-1 in early (type A) spermatogonial
cells at stages II-V of rat testis but not mouse testis sections
may be attributable to greater homology of the epitope
(residues 342–386 of the human sequence) used to raise
the KH-129 monoclonal antibody to the corresponding
rat sequence. Anyway, very early type A spermatogonia,
that might represent true spermatogonial stem cells
(SSCs), are notoriously elusive to IHC staining. Still, the
observation of Sertoli-cell-only tubules in E2F-1 -/- indi-
cates that E2F-1 is likely expressed and activating gene
programs required for proliferation in renewal as well as
differentiation of SSCs. Other immunohistochemical
studies conducted in our lab on sections from excised
human testicular tumors have demonstrated that E2F-1 is
strongly expressed in carcinoma in situ (data not submit-
Immunohistochemical staining of section from testis of rat with antibody against E2F-5 Figure 7
Immunohistochemical staining of section from testis of rat with antibody against E2F-5. Labels are: for germline type A sperma-
togonia (A), intermediate (I) and B-type (B) spermatogonia, preleptotene (Pl), pachythene (P), zygotene (Z), and diplotene 
(D)spermatocytes, spermatids (s), and for somatic Sertoli cell (S), Leydig cell (L), and peritubular myoid cell (M); stages indi-
cated by Roman numerals I-XIV for rat.
RatReproductive Biology and Endocrinology 2006, 4:63 http://www.rbej.com/content/4/1/63
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ted), supporting its role in initiating proliferation of SSCs
in testis.
Staining of leptotene to early pachytene spermatocytes at
stages IX to XI of wildtype mouse, and the conservation of
such a staining pattern in the rat indicate that these cells
are most likely to require E2F-1 regulated gene expression
for the transition through prophase of meiosis I. It is con-
ceivable that E2F-1 might also be responsible for activat-
ing the expression of pro-apoptosis genes in these cell
types when stabilized by checkpoint proteins in the
response to DNA double-strand breaks caused by genoto-
xic insult. In fact, apoptosis is mostly observed in the very
cell types and stages in which we observe most E2F-1 in
the testis. Such duality in the role of E2F-1 in the testis
might explain why its level appears diminished in "runa-
way" seminomatous tumours of testis (data not submit-
ted).
E2F-2
The observation of E2F-2 expression in cells wherein p107
had also been localized to a lesser extent (fig. 8), and
wherein pRb was absent, is somewhat unexpected. How-
ever, others have observed that G1 CDKs can phosphor-
ylate p107 to an extent which increases its binding to E2F-
1 at least transiently [24], though p107 otherwise displays
a preference for binding E2F-4. Perhaps site-specific phos-
phorylation of p107 by cyclin A1 [25] or cyclin E2 [26]
and cdk2 [27] enables it to interact with E2F-2 during mei-
osis. Alternatively, E2F-2 might be acting independently
Immunohistochemical staining of section from testis of rat with antibody against p107 Figure 8
Immunohistochemical staining of section from testis of rat with antibody against p107.
Rat
20xReproductive Biology and Endocrinology 2006, 4:63 http://www.rbej.com/content/4/1/63
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of p107 at these specific stages of spermatogenesis. Never-
theless, E2F-2 -/- mice were fertile [17] and no abnormal
histology of testis was reported for the E2F-2 knockout or
E2F-2/E2F-1 DKO mice. This indicates that another mem-
ber of the E2F family might be able to compensate at this
stage.
E2F-3
The prevalence of E2F-3 in spermatogonia of stages II to
IV, and Sertoli cells of other stages, is especially notewor-
thy in light of the observation by others that E2F-1 -/- E2F-
3 +/- DKO mice display an accelerated atrophy in testis
development compared to just E2F-1 -/- [12] However,
staining of spermatogonia might also be explained by
possible cross-reactivity of the monoclonal antibody used
to detect E2F-3 for E2F-1. Compound E2F-1 -/- E2F-3 +/-
DKO males have severely atrophied testis and tubules
already at 4 months (120 days) of age. The phenotype
observed for the DKO indicates E2F-1 is indispensable for
spermatogonial stem cell renewal. Our observation of
E2F-3 in Sertoli cells might explain how a malfunction of
Sertoli cells in the DKO could exacerbate the E2F-1 phe-
notype, since proper Sertoli cell function is necessary for
normal maintenance of the testis. Combinatorial interac-
Immunohistochemical staining of section from testis of rat with antibody against SMADs 1/2/3 Figure 9
Immunohistochemical staining of section from testis of rat with antibody against SMADs 1/2/3. Labels are: for germline type A 
spermatogonia (A), intermediate (I) and B-type (B) spermatogonia, preleptotene (Pl), pachythene (P), zygotene (Z), and diplo-
tene (D)spermatocytes, spermatids (s), and for somatic Sertoli cell (S), Leydig cell (L), and peritubular myoid cell (M); stages 
indicated by Roman numerals I-XIV for rat.
Rat
10xReproductive Biology and Endocrinology 2006, 4:63 http://www.rbej.com/content/4/1/63
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tions between the functionalities of E2F-1 and E2F-3 have
been recently characterized [28].
E2F-4
The localization of E2F-4 to the same somatic cell com-
partment, the Sertoli cells, as p130 was previously
mapped to agrees with the paradigm of its role in main-
taining terminally differentiated states by repressing the
expression of genes expressed in cycling cells. Further-
more, the increasing level of E2F-4 protein detected from
stages VII on could relate to the testosterone sensitivity of
Sertoli cells during this period of the seminiferous epithe-
lial cycle.
E2F-5
This localization of E2F-5 resembles that of p107 (Fig. 8),
which was determined from earlier studies (Fig. 18) to be
expressed throughout meiosis. Furthermore, when com-
pared to the staining of young primary spermatocytes
with antibodies against the SMADs (Figures 9 and 10), it
is possible to envision how E2F-5 might interact with
p107, activated SMADS 2/3 and SMAD 4 to be tranlocated
Immunohistochemical staining of section from testis of rat with antibody against SMAD 4 Figure 10
Immunohistochemical staining of section from testis of rat with antibody against SMAD 4. Labels are: for germline type A sper-
matogonia (A), intermediate (I) and B-type (B) spermatogonia, preleptotene (Pl), pachythene (P), zygotene (Z), and diplotene 
(D)spermatocytes, spermatids (s), and for somatic Sertoli cell (S), Leydig cell (L), and peritubular myoid cell (M); stages indi-
cated by Roman numerals I-XIV for rat.
Rat
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to the nucleus [29] in leptotene, zygotene and early pach-
ytene spermatocytes of stages VI to XIV. Such a tripartite
complex interaction has been recently demonstrated for
TGF-beta mediated repression of replication of cells in
culture [30]. However, the IHC of rat testis displaying a
localization of E2F-5 distinct from that of E2F-4 and over-
lapping those of E2F-1 and E2F-2 might also be explained
by a possibility of cross-reactivity of the monoclonal anti-
body used to detect E2F-5 with the E2F-1 and E2F-2 of rat,
since we were not able to detect any significant signals
from staining of mouse testis sections.
Distinct localizations of E2F-1 and E2F-4
This observation fits nicely with the scheme of spermato-
gonial development presented in Figure 1, since E2F-1 is
considered a key transcription factor capable of transacti-
vating the expression of numerous proteins required for
DNA replication and the transition to S phase of the cell
cycle in actively proliferating cells. E2F-1 is also somewhat
unique in its dual capacity to transactivate the expression
of pro-apoptotic genes in response to DNA-damage-acti-
vated checkpoints at the S/G2 transition, and perhaps this
dualism in E2F-1's roles is related to the observation that
Chart of immunohistochemical staining of E2F-1, in cells and stages of rat seminiferous tubule cycle Figure 11
Chart of immunohistochemical staining of E2F-1, in cells and stages of rat seminiferous tubule cycle. The width of shading indi-
cates intensity of staining. Abbreviations: As = spermatogonial stem cell, As-pr = paired spermatogonia, As-pr-al = paired and 
aligned spermatogonia, Aal-n = aligned spermatogonia of n number of cells, An = differentiated type A spermatogonia entering 
synchronised division number n, In = intermediate type spermatogonia, B = B-type spermatogonia which undergo final mitotic 
division before replication and division for Meiosis I, Pl = preleptotene, L = leptotene, Z = zygotene, P = pachythene, m = mei-
osis, In = intermediate, and Sc = Sertoli cell.Reproductive Biology and Endocrinology 2006, 4:63 http://www.rbej.com/content/4/1/63
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apoptosis of spermatogonia coincides (Fig. 1) with the
stages of peak E2F-1 levels. In contrast, E2F-5 might be
expected to repress the expression of S phase genes [31],
while phosphorylated E2F-5 could function as a coactiva-
tor and autoregulator of late G1 and S phase genes as
observed by others [32], perhaps transactivating the
expression of the meiosis-specific Cyclin E2 or Cyclin A,
and possibly other genes required for meiosis and differ-
entiation [16,33].
Conclusion
The observations described above indicate a scenario (Fig.
18) wherein E2F-1 is expressed in very young type A sper-
matogonial (stem) cells, suggesting that E2F-1 is a key
transcription factor in activating the expression of genes
necessary for entering the proliferative phase of sperma-
togenesis. This might follow p130 phosphorylation and
inactivation in response to paracrine GDNF secretion
from Sertoli cells stimulated by the endocrine gonadotro-
pin FSH. It is quite possible that pRb levels increase at this
point in order to maintain a check on E2F-1 and its pro-
apoptotic activities. That E2F-1, E2F-5 and E2F-2 are the
principle members of the E2F family present in germ cells
during meiosis, alongside our previous observation that
the only member of the retinoblastoma protein family to
be expressed throughout this period is p107 suggests that
these three E2Fs are interacting with p107 in order to tar-
get its repressive role to specific genes. Otherwise, they
Chart of immunohistochemical staining of E2F-2, in cells and stages of rat seminiferous tubule cycle Figure 12
Chart of immunohistochemical staining of E2F-2, in cells and stages of rat seminiferous tubule cycle. The width of shading indi-
cates intensity of staining. Abbreviations: As = spermatogonial stem cell, As-pr = paired spermatogonia, As-pr-al = paired and 
aligned spermatogonia, Aal-n = aligned spermatogonia of n number of cells, An = differentiated type A spermatogonia entering 
synchronised division number n, In = intermediate type spermatogonia, B = B-type spermatogonia which undergo final mitotic 
division before replication and division for Meiosis I, Pl = preleptotene, L = leptotene, Z = zygotene, P = pachythene, m = mei-
osis, In = intermediate, and Sc = Sertoli cell.Reproductive Biology and Endocrinology 2006, 4:63 http://www.rbej.com/content/4/1/63
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could be acting independently of a retinoblastoma pro-
tein in regulating the expression of different sets of genes
at different stages of the extended prophase of meiosis.
E2F-3 appears to be serving dual roles in Sertoli cells and
late spermatogonia, most likely under the hormone-
responsive control of pRb. This later observation presents
the tantalizing prospect that E2F-3 might actually be inter-
acting with the androgen receptor (AR) of Sertoli cells via
its Rb partner, since it has been previously demonstrated
by others that pRb can serve a coactivator role in com-
plexes with AR. In germ cells, E2F-3 appears to be filling
in a gap between E2F-1 and E2F-5 at the intermediate
stage between type A and type B spermatogonia, possibly
activating the expression of genes required for commit-
ment to the differentiative pathway, following inactiva-
tion of pRb in response to the SCF ligand. In Sertoli cells,
E2F-3 is most likely checked by pRb, but then released and
activating the expression of genes in a signal transduction
cascade response to stimulation by gonadotropins and
testosterone. It is conceivable that there is an overlap of
target genes controlled by E2F-3 and E2F-4 in Sertoli cells.
This could be resolved at least in part by ongoing chroma-
tin immunoprecipitation for genomic microarray (ChIP-
on-chip) studies to ascertain the target genes of E2Fs
expressed in testis. Another key question is the identity of
Chart of immunohistochemical staining of E2F-3, in cells and stages of rat seminiferous tubule cycle Figure 13
Chart of immunohistochemical staining of E2F-3, in cells and stages of rat seminiferous tubule cycle. The width of shading indi-
cates intensity of staining. Abbreviations: As = spermatogonial stem cell, As-pr = paired spermatogonia, As-pr-al = paired and 
aligned spermatogonia, Aal-n = aligned spermatogonia of n number of cells, An = differentiated type A spermatogonia entering 
synchronised division number n, In = intermediate type spermatogonia, B = B-type spermatogonia which undergo final mitotic 
division before replication and division for Meiosis I, Pl = preleptotene, L = leptotene, Z = zygotene, P = pachythene, m = mei-
osis, In = intermediate, and Sc = Sertoli cell.Reproductive Biology and Endocrinology 2006, 4:63 http://www.rbej.com/content/4/1/63
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the E2F that interacts with p130 in quiescent spermatogo-
nial stem cells.
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Chart of immunohistochemical staining of E2F-4, in cells and stages of rat seminiferous tubule cycle. The width of shading indi-
cates intensity of staining. Abbreviations: As = spermatogonial stem cell, As-pr = paired spermatogonia, As-pr-al = paired and 
aligned spermatogonia, Aal-n = aligned spermatogonia of n number of cells, An = differentiated type A spermatogonia entering 
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Chart of immunohistochemical staining of E2F-5, in cells and stages of rat seminiferous tubule cycle Figure 15
Chart of immunohistochemical staining of E2F-5, in cells and stages of rat seminiferous tubule cycle. The width of shading indi-
cates intensity of staining. Abbreviations: As = spermatogonial stem cell, As-pr = paired spermatogonia, As-pr-al = paired and 
aligned spermatogonia, Aal-n = aligned spermatogonia of n number of cells, An = differentiated type A spermatogonia entering 
synchronised division number n, In = intermediate type spermatogonia, B = B-type spermatogonia which undergo final mitotic 
division before replication and division for Meiosis I, Pl = preleptotene, L = leptotene, Z = zygotene, P = pachythene, m = mei-
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Plot of specific protein level, and immunostained Western blot representative of four different sets, for E2F-1, and GAPDH, in  total proteins extracted from three pooled stages of mouse Figure 16
Plot of specific protein level, and immunostained Western blot representative of four different sets, for E2F-1, and GAPDH, in 
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Plot of specific protein level, and immunostained Western blot representative of four different sets, for E2F-4, and GAPDH, in  total proteins extracted from three pooled stages of mouse Figure 17
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